Unity Biotechnology, Inc. — Form D/A
Unity Biotechnology, Inc. of BRISBANE, CA, a company, filed a Form D amendment with the SEC on 2017-08-21. The offering totals $177.6M, of which $151.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-21
- Form: D/A
- Accession: 0001140361-17-032844
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $177.6M
- Amount sold: $151.2M
- Remaining: $26.4M
- Investors: 38
- Date of first sale: 2016-10-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275461
Issuer
- Name: Unity Biotechnology, Inc.
- CIK: 0001463361
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 3280 BAYSHORE BOULEVARD, BRISBANE, CA, 94005
- Phone: (650) 416-1192
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| John E Smither | Executive Officer | Brisbane, CA |
| Robert Nelsen | Director | Seattle, WA |
| Kristina Burow | Director | San Diego, CA |
| Kristina E Burow | Director | LA JOLLA, CA |
| Dan E Marquess | Executive Officer | Brisbane, CA |
| Keith E Leonard | Director | Brisbane, CA |
| Keith E Leonard | Executive Officer | Brisbane, CA |
| Tamara E Tompkins | Executive Officer | Brisbane, CA |
| Paul E Berns | Director | Brisbane, CA |
| Bob E Goeltz | Executive Officer | Brisbane, CA |
| Robert E Nelsen | Director | Brisbane, CA |
| Camille E Samuels | Director | Brisbane, CA |
| Jamie E Dananberg | Executive Officer | Brisbane, CA |
| Nathaniel E David | Director | Brisbane, CA |
| Nathaniel E David | Executive Officer | Brisbane, CA |
| Graham E Cooper | Director | Brisbane, CA |
| Keith E Klein | Executive Officer | Brisbane, CA |
| Nathaniel David | Director | San Francisco, CA |
| Nathaniel David | Executive Officer | San Francisco, CA |
| Troy Foster | Executive Officer | Palo Alto, CA |
Other filings by this issuer (5)
More